Teva Pharmaceutical Industries Limited reaffirmed earnings guidance for the full year 2024. For the year, the company expects Revenues of $15.7 - $16.3 billion.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
16.45 USD | -1.85% | -2.55% | +57.57% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+57.57% | 18.63B | |
+39.22% | 731B | |
+30.57% | 586B | |
-7.85% | 348B | |
+15.48% | 319B | |
-0.12% | 273B | |
+12.55% | 235B | |
+6.65% | 202B | |
-6.09% | 203B | |
-3.37% | 158B |
- Stock Market
- Equities
- TEVA Stock
- News Teva Pharmaceutical Industries Limited
- Teva Pharmaceutical Industries Limited Reaffirms Earnings Guidance for the Full Year 2024